Total Payments
$2,893
2024 Payments
$383.41
Companies
28
Transactions
171
Medicare Patients
2,720
Medicare Billing
$137,693
Payment Breakdown by Category
Food & Beverage$2,748 (95.0%)
Education$145.04 (5.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,748 | 169 | 95.0% |
| Education | $145.04 | 2 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $730.04 | 46 | $0 (2024) |
| Janssen Biotech, Inc. | $270.46 | 17 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $238.07 | 13 | $0 (2024) |
| ABBVIE INC. | $230.10 | 15 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $197.52 | 12 | $0 (2019) |
| COLOPLAST CORP | $186.56 | 13 | $0 (2021) |
| UROVANT SCIENCES INC | $159.27 | 9 | $0 (2022) |
| PFIZER INC. | $91.51 | 5 | $0 (2024) |
| Allergan, Inc. | $90.78 | 6 | $0 (2021) |
| Endo Pharmaceuticals Inc. | $81.53 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $383.41 | 17 | Sumitomo Pharma America, Inc. ($134.31) |
| 2023 | $202.08 | 11 | Sumitomo Pharma America, Inc. ($103.76) |
| 2022 | $271.07 | 15 | UROVANT SCIENCES INC ($141.15) |
| 2021 | $568.41 | 33 | COLOPLAST CORP ($127.19) |
| 2020 | $131.67 | 8 | Astellas Pharma US Inc ($64.72) |
| 2019 | $356.89 | 20 | Astellas Pharma US Inc ($132.88) |
| 2018 | $428.11 | 30 | Astellas Pharma US Inc ($158.89) |
| 2017 | $551.65 | 37 | Astellas Pharma US Inc ($159.64) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: UROLOGY | ||||||
| 12/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $3.62 | General |
| Category: UROLOGY | ||||||
| 11/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: UROLOGY | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: UROLOGY | ||||||
| 09/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: UROLOGY | ||||||
| 06/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: UROLOGY | ||||||
| 05/14/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.05 | General |
| 04/22/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 04/17/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $20.05 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 03/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: UROLOGY | ||||||
| 01/31/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 01/29/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Oncology | ||||||
| 01/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: UROLOGY | ||||||
| 11/20/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Urology | ||||||
| 10/19/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/20/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Urology | ||||||
| 09/18/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: ONCOLOGY | ||||||
| 06/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Urology | ||||||
| 06/26/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 04/18/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 550 | 778 | $75,464 | $25,863 |
| 2022 | 8 | 635 | 914 | $88,976 | $30,930 |
| 2021 | 9 | 827 | 1,326 | $129,099 | $46,647 |
| 2020 | 9 | 708 | 1,129 | $97,855 | $34,252 |
Total Patients
2,720
Total Services
4,147
Medicare Billing
$137,693
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 225 | $39,150 | $12,925 | 33.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 23 | 27 | $12,521 | $4,514 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 46 | $11,514 | $4,017 | 34.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 36 | $4,068 | $1,479 | 36.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 24 | 63 | $2,818 | $997.50 | 35.4% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 12 | 13 | $2,713 | $843.35 | 31.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 205 | 312 | $1,560 | $686.40 | 44.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 34 | 56 | $1,120 | $401.00 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 195 | 239 | $43,260 | $14,889 | 34.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 22 | 32 | $14,784 | $5,354 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 42 | $10,710 | $3,404 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $6,760 | $2,331 | 34.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 44 | 53 | $5,989 | $2,102 | 35.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 50 | 107 | $4,708 | $1,732 | 36.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 235 | 377 | $1,885 | $829.41 | 44.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 32 | 44 | $880.00 | $288.68 | 32.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 194 | 259 | $47,112 | $16,650 | 35.3% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 47 | 59 | $27,243 | $9,859 | 36.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 69 | 85 | $21,996 | $8,052 | 36.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 37 | 37 | $12,506 | $4,371 | 34.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 59 | 77 | $8,547 | $3,266 | 38.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 64 | 132 | $5,806 | $2,158 | 37.2% |
| 81003 | Automated urinalysis test | Office | 2021 | 283 | 537 | $2,685 | $1,191 | 44.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 56 | 89 | $1,780 | $619.85 | 34.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 18 | 51 | $1,424 | $479.66 | 33.7% |
About Dr. Walter Levy, MD
Dr. Walter Levy, MD is a Specialist healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356333199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Walter Levy, MD has received a total of $2,893 in payments from pharmaceutical and medical device companies, with $383.41 received in 2024. These payments were reported across 171 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,748).
As a Medicare-enrolled provider, Levy has provided services to 2,720 Medicare beneficiaries, totaling 4,147 services with total Medicare billing of $137,693. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Metairie, LA
- Active Since 08/18/2005
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1356333199
Products in Payments
- GEMTESA (Drug) $397.34
- MYRBETRIQ (Drug) $327.71
- Myrbetriq (Drug) $197.99
- Androgel (Drug) $160.39
- FIRMAGON (Drug) $130.14
- ERLEADA (Drug) $115.95
- XYOSTED (Drug) $114.43
- Erleada (Drug) $103.88
- XTANDI (Drug) $95.47
- Natesto (Drug) $80.78
- UroLift System (Device) $75.71
- BOTOX (Biological) $71.94
- XIAFLEX (Biological) $67.61
- NOCDURNA (Drug) $67.38
- SpaceOAR (Device) $65.40
- SpeediCath (Device) $64.69
- LUPRON DEPOT (Drug) $51.43
- ReTrace (Device) $43.74
- PYLARIFY (Drug) $38.11
- Xofigo (Drug) $31.02
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Metairie
Dr. Patricia Farris, M.d, M.D
Specialist — Payments: $121,914
Specialist $121,914
Kamran Khoobehi, Md, MD
Specialist — Payments: $30,616
Specialist $30,616
Dr. Barbara Bopp, M.d, M.D
Specialist — Payments: $30,385
Specialist $30,385
Dr. Joseph Uddo, M.d, M.D
Specialist — Payments: $18,816
Specialist $18,816
Dr. James Rooney, M.d, M.D
Specialist — Payments: $18,407
Specialist $18,407
Dr. Felix Bopp, M.d, M.D
Specialist — Payments: $17,391
Specialist $17,391